While the No Surprises Act (NSA) of 2020 has undeniably succeeded in its primary mission—shielding patients from the financial shock of unexpected medical bills—the infrastructure built to support it has morphed into a high-stakes, multi-billion-dollar battleground. According to the latest federal data released by the Centers for Medicare & Medicaid Services (CMS), the Independent Dispute Resolution (IDR) process is not merely active; it is snowballing, creating a fiscal feedback loop that regulators, insurers, and economists are increasingly viewing with alarm.
The State of the Dispute Landscape: Key Facts and Figures
The data released this Wednesday for the second half of 2025 paints a picture of a system under immense pressure. Between July and December 2025, providers and payers initiated nearly 1.4 million disputes—a 16% increase over the first half of the year. This surge confirms that the "safety valve" created by the NSA has become a central feature of the healthcare revenue cycle.
The mechanics of the IDR are straightforward in theory but complex in practice: when a provider and an insurer cannot agree on a payment rate for out-of-network services, they enter a "baseball-style" arbitration. Both parties submit a final offer, and a government-certified arbiter must select one.
However, the reality of the process is heavily skewed. CMS data reveals that providers initiated 76% of all disputes during the latter half of 2025. Even more striking is the success rate: providers were the prevailing party in approximately 85% of these cases. In 87% of those instances, the final, binding award was higher than the "qualifying payment amount" (QPA), which is defined as the median contracted rate for a similar service in the same geographic area.
A Chronology of the NSA’s Implementation
To understand how the IDR reached this point of saturation, one must look back at the law’s inception and its subsequent implementation:
- 2020: The No Surprises Act is signed into law with bipartisan support, aiming to end the practice of "surprise billing," where patients are left responsible for the gap between what an insurer covers and what an out-of-network provider charges.
- 2022: The IDR portal goes live. The system is immediately overwhelmed by a deluge of claims, far exceeding the administration’s initial volume estimates. A significant backlog develops as arbiters struggle to define the rules of eligibility.
- 2023–2024: Multiple lawsuits are filed by provider groups and insurers, challenging the CMS’s regulatory guidance on how arbiters should weigh the QPA against other factors, such as provider training and market share.
- 2025 (First Half): Dispute volume remains high, though regulatory tweaks begin to help arbiters clear the backlog.
- 2025 (Second Half): The total payout under the IDR process reaches nearly $15 billion for the year—more than triple the amount from the previous year.
Concentration of Power: Who is Driving the Disputes?
The sheer volume of disputes is not distributed evenly across the medical landscape. CMS data indicates that the "litigation-heavy" nature of the IDR process is driven by a small, concentrated group of participants. The top 10 initiating parties accounted for roughly 66% of all disputes in the latter half of 2025.
At the epicenter of this activity are three entities: HaloMD, a billing intermediary, and large physician staffing firms Team Health and SCP Health. Together, these three entities were responsible for 38% of all disputes in the second half of 2025.
The role of HaloMD, in particular, has drawn intense scrutiny. Several major insurance carriers have launched litigation against the firm, alleging that it is "gaming" the system by using algorithmic billing strategies to systematically inflate claims. While federal judges have dismissed some of these suits—often on the grounds that the courts lack the authority to intervene in the administrative process of the NSA—the legal friction underscores the deep-seated distrust between stakeholders.
The Economic Implications: A $15 Billion Burden
The financial consequences of these disputes extend far beyond the balance sheets of individual hospitals and insurers. According to a comprehensive analysis of the CMS data by The Wall Street Journal, the total payout under the NSA process reached $15 billion in 2025. This figure is more than six times what providers would have received had the care been provided on an in-network basis.
Health economists warn that this "arbitration premium" is not being absorbed by insurance companies; it is being passed down the line. As insurers pay out significantly higher rates through the IDR process than they would through standard contract negotiations, these costs are reflected in higher premiums for employers and individual policyholders. Essentially, the very mechanism designed to protect patients from individual financial ruin may be contributing to the broader, systemic inflation of healthcare costs.
Official Responses and Regulatory Maneuvers
The CMS has acknowledged that the system is currently unbalanced. A spokesperson for the agency stated, "While patients are now protected from surprise bills, the system is being gamed to get higher prices, and CMS is actively working to clean it up."
The administration has been attempting to course-correct. This past spring, the government finalized a new rule designed to patch loopholes in the IDR process. The updates focus on tightening the criteria for "eligibility"—a critical move, as the number of disputes challenged for being ineligible for the IDR process remains high, hovering around 42%. By standardizing communication and cutting down on frivolous or ineligible filings, the government hopes to reduce the administrative burden on the system.
However, industry groups remain skeptical. The Coalition Against Surprise Medical Billing, which represents a broad swath of employers and insurers, issued a sharp rebuke following the release of the latest data. "Extreme IDR award after extreme IDR award is now the norm," the group stated. "Congress and the administration cannot delay in overhauling the IDR system that is in desperate need of reform."
Efficiency Gains vs. Structural Flaws
Despite the controversy, there are signs that the operational side of the IDR process is maturing. The backlog that once plagued the system has been significantly reduced. By the end of 2025, nearly all disputes submitted since the inception of the program in 2022 had been resolved or were in the final stages of processing.
Regulators point to the onboarding of new, certified IDR entities—which increased the total processing capacity—as a primary driver for this improvement. Furthermore, the speed of decision-making has increased dramatically: 62% of payment determinations were rendered within 30 business days in the latter half of 2025, compared to just 37% in the first half.
"Certified IDR entities have achieved remarkable improvements in throughput and processing speed," regulators noted in their report. "The resolution of aged disputes marks significant improvement in the efficiency of the IDR process."
Conclusion: The Path Forward
The No Surprises Act has achieved its goal of removing the patient from the middle of billing disputes. Yet, in doing so, it has created a shadow economy of arbitration that is ballooning in cost and complexity.
The central challenge for policymakers moving forward is twofold: they must continue to protect the patient while ensuring that the IDR process does not become a vehicle for systemic price gouging. As the data shows, the system is no longer in its "infancy" phase. It is a mature, high-volume, and highly contested financial engine. Whether through further legislative reform or tighter administrative oversight, the federal government faces a tall task in ensuring that the cost of "no surprises" does not eventually become a surprise of its own.
